Invention Grant
- Patent Title: Selective inhibition of V1b for treating fatty liver
-
Application No.: US16131410Application Date: 2018-09-14
-
Publication No.: US11033601B2Publication Date: 2021-06-15
- Inventor: Richard J. Johnson , Miguel A. Lanaspa Garcia , Thomas Jensen
- Applicant: The Regents of the University of Colorado
- Applicant Address: US CO Denver
- Assignee: The Regents of the University of Colorado
- Current Assignee: The Regents of the University of Colorado
- Current Assignee Address: US CO Denver
- Agency: Wolter Van Dyke Davis, PLLC
- Agent Timothy H. Van Dyke
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/404 ; A61K45/06 ; A61K38/095
Abstract:
Disclosed herein are methods and compositions for treating nonalcoholic fatty liver disease. Specifically exemplified herein is administration of compositions comprising a V1b inhibitor or V1a agonist or V1a stabilizer.
Public/Granted literature
- US20190083568A1 SELECTIVE INHIBITION OF V1b AND/OR STABILIZATION OR UPREGULATION OF V1a FOR TREATING FATTY LIVER Public/Granted day:2019-03-21
Information query
IPC分类:
